ICICI Prudential Life Insurance Ltd. – Q2 FY27 Performance

Executive Summary Shares of ICICI Prudential Life Insurance gained upward momentum following its Q2 FY27 earnings release, supported by double-digit operational growth and compelling long-term valuations. Despite missing certain street estimates on margins, leading global brokerages maintain strong bullish conviction, projecting an upside potential of up to 59%. Operational & Financial Highlights Value of New Business (VNB): Q2 VNB rose 20.7% year-over-year to ₹712 crore (versus estimate of ₹722 crore). VNB margin expanded year-over-year to 25.43% from 24.00%, driven by an improved product mix. Premium Collections: Annual Premium Equivalent (APE) grew 16.6% year-over-year to ₹2,799 crore, while Retail APE rose 10.7% to ₹2,221 crore, reflecting stable retail execution. H1 FY27 Aggregates: First-half VNB expanded 22.3% to ₹1,283 crore with a 26% margin. Profit after tax jumped 26.5% to ₹760 crore, buoyed by higher shareholder investment income and healthy surplus generation. Analyst Perspectives & Price Targets Nomura (Buy | Target: ₹710 | +59% Upside): Underlines healthy non-participating momentum and accelerated agency channel expansion; anticipates 14% VNB growth for the full fiscal year despite high-base effects. JPMorgan (Overweight | Target: ₹670 | +50% Upside): Observes sequential margin moderation to 25.4% due to reduced protection mix, yet sees strong bounce potential supported by discounted multiples. HSBC (Buy | Target: ₹582 | +30% Upside): Highlights that trading around 1x FY28 estimated embedded value provides robust downside protection and an attractive risk-reward profile. Valuation & Market Context Trading near ₹453, the stock remains down roughly 33% year-to-date and hovers near its 52-week low. Bloomberg consensus indicates zero "Sell" ratings across 36 tracking analysts (33 Buys, 3 Holds), with a 12-month mean target of ₹621.41 (+39% upside), presenting an opportune institutional entry level.